Symmetry Peak Management’s Guardant Health GH Stock Holding History

Symmetry Peak Management’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-5,000	Closed	-$391K	–	48
2019 Q4	$391K	Buy	+5,000	New	+$360K	0.09%	123

Other funds holding GH

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.73B AUM 2.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Symmetry Peak Management's GH Position: Q1 2020 in Review

Symmetry Peak Management sold out of Guardant Health (GH) in Q1 2020, closing a stake of 5,000 shares — an estimated $391K sold.

Symmetry Peak Management first reported a position in GH in Q2 2019 and held it in 2 quarters. The position peaked at $483K in Q2 2019. 288 funds tracked by Wall St. Rank hold GH as of Q1 2020.

Symmetry Peak Management reported no remaining Guardant Health position as of Q1 2020 after selling out during the quarter.
Symmetry Peak Management sold 5,000 Guardant Health shares in Q1 2020, an estimated $391K.
Symmetry Peak Management first reported a position in Guardant Health in Q2 2019 and held it in 2 quarters.
Symmetry Peak Management's Guardant Health position peaked at $483K in Q2 2019.
288 funds tracked by Wall St. Rank held Guardant Health as of Q1 2020.

Based on Symmetry Peak Management's 13F filing for Q1 2020, filed 15 May 2020.